| |
| |
|
| Insider
Information: |
Bradsher Neal C |
| Relationship: |
10% Owner |
| City: |
Union City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
129,185 |
|
|
Indirect Shares
|
57,363,752 |
|
|
| Direct
Value |
$1,156,585 |
|
|
|
Indirect Value
|
$486,514,725 |
|
|
| Total
Shares |
57,492,937 |
|
|
| Total
Value |
$487,671,310 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
60
|
50
|
|
Stock
price went up :
|
36
|
16
|
| Stock
price went down : |
24
|
34
|
| |
|
|
|
Gain/Loss Ratio : |
1.5
|
1.5
|
| Percentage
Gain/Loss : |
 6.9%
|
 -929.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Questcor Pharmaceuticals Inc |
QCOR |
Director |
2014-08-14 |
0 |
2014-08-14 |
0 |
Premium* |
|
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director, 10% Owner |
2024-02-06 |
87,628 |
2024-02-06 |
41,666,255 |
Premium* |
|
|
Comarco Inc |
CMRO |
10% Owner |
2017-09-15 |
15,500 |
2017-09-15 |
0 |
Premium* |
|
|
STAAR Surgical Co |
STAA |
10% Owner |
2024-05-09 |
25,900 |
2024-05-09 |
10,768,431 |
Premium* |
|
|
Palomar Medical Technologies Inc |
PMTI |
10% Owner |
2013-06-24 |
0 |
2013-06-24 |
0 |
Premium* |
|
|
Asterias Biotherapeutics Inc |
AST |
See Remarks Below |
2019-03-08 |
0 |
2019-03-08 |
0 |
Premium* |
|
|
Oncocyte Corp |
OCX |
10% Owner |
2024-04-11 |
157 |
2024-04-11 |
4,929,066 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
612 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 13 of 25
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2023-09-21 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
9,264,427 |
1.42 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2023-10-04 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
9,296,950 |
1.42 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2023-10-05 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
9,394,424 |
1.42 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2023-10-06 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
9,469,723 |
1.42 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2023-11-02 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
9,613,750 |
1.42 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2023-11-03 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
9,614,270 |
1.42 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2023-11-06 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
9,778,877 |
1.42 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2023-11-10 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
10,102,337 |
1.42 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2023-11-13 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
10,102,844 |
1.42 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2023-11-28 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
10,199,828 |
1.42 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2023-11-29 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
10,360,128 |
1.42 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2023-11-30 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
10,537,835 |
1.42 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2024-01-03 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
10,544,408 |
1.42 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2024-01-04 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
10,607,654 |
1.42 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2024-01-05 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
10,764,388 |
1.42 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2024-01-08 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
10,768,430 |
1.42 |
% |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2024-02-06 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
41,666,255 |
2.17 |
- |
|
| OCX |
Oncocyte Corp |
10% Owner |
– – • |
2024-04-11 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
4,929,066 |
1.42 |
- |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2024-05-09 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
10,768,431 |
1.42 |
% |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2007-12-21 |
4 |
S |
$0.30 |
$80,210 |
D/D |
(267,365) |
1,650,805 |
0 |
- |
|
| OCX |
Oncocyte Corp |
10% Owner |
– – • |
2023-04-03 |
4 |
B |
$0.30 |
$8,093,898 |
D/D |
26,827,638 |
50,181,335 |
2.45 |
% |
|
| QCOR |
Questcor Pharmaceuticals ... |
Director |
– • – |
2007-03-15 |
4 |
B |
$0.75 |
$323,436 |
I/I |
425,300 |
3,578,660 |
2.1 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Director |
– • – |
2005-11-01 |
4 |
B |
$0.80 |
$329,199 |
I/I |
413,100 |
2,595,260 |
2.1 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Director |
– • – |
2005-11-02 |
4 |
B |
$0.80 |
$98,135 |
I/I |
123,100 |
2,718,360 |
2.1 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Director |
– • – |
2013-11-14 |
4 |
OE |
$0.83 |
$34,250 |
D/D |
40,000 |
44,183 |
0 |
- |
|
612 Records found
|
|
Page 13 of 25 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
